Therefore, MDM2 amplification was not the major mechanism of MDM2 expression in our patient population, which aligns with previous studies reporting rare MDM2 amplification in pancreatic adenocarcinoma [41]. This evidence concerns the gene MDM2 and pancreatic adenocarcinoma.